EPO Patents = 1

Forward Citations = 3

Loading Chart...

1 inventor (with patents filed for the assignee):

Kunwar Shailubhai (4 out of 51 patents)

4 patents: Sort by Forward Citations

1. 11975111 - Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia (2024-05-07),

2. 10973773 - Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia (2021-04-13),

3. 10758541 - Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer (2020-09-01),

4. 10688186 - Anti-CD3 antibody formulations (2020-06-23),

Company Overview

Tiziana Life Sciences Plc is a biotechnology company focused on the discovery and development of novel molecules to treat diseases with high unmet medical need. Their innovative pipeline includes potential therapies for cancer, autoimmune and inflammatory diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#657 in London

#3,869 in United Kingdom

London, United Kingdom

Tiziana Life Sciences Plc

Forward Citations = 3

1 inventor:

Kunwar Shailubhai (4 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tiziana Life Sciences Plc. Retrieved from https://idiyas.com/company/tiziana-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]